| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Memory | 40 | 2020 | 170 | 7.820 |
Why?
|
| Dendritic Spines | 20 | 2023 | 33 | 7.010 |
Why?
|
| Estradiol | 52 | 2020 | 262 | 6.930 |
Why?
|
| Biogenic Monoamines | 17 | 2010 | 31 | 3.050 |
Why?
|
| Estrogens | 20 | 2022 | 202 | 2.990 |
Why?
|
| Cognition | 16 | 2023 | 398 | 2.810 |
Why?
|
| Sex Characteristics | 15 | 2022 | 230 | 2.370 |
Why?
|
| Hippocampus | 36 | 2021 | 561 | 2.360 |
Why?
|
| Stress, Physiological | 13 | 2015 | 150 | 2.170 |
Why?
|
| Stress, Psychological | 10 | 2016 | 583 | 2.060 |
Why?
|
| Phenols | 8 | 2020 | 80 | 2.010 |
Why?
|
| Rats | 101 | 2022 | 3483 | 1.940 |
Why?
|
| Animals | 141 | 2023 | 15081 | 1.830 |
Why?
|
| Prefrontal Cortex | 16 | 2020 | 137 | 1.720 |
Why?
|
| Rats, Sprague-Dawley | 41 | 2017 | 1618 | 1.710 |
Why?
|
| Space Perception | 15 | 2008 | 33 | 1.670 |
Why?
|
| Brain | 39 | 2012 | 1346 | 1.620 |
Why?
|
| CA1 Region, Hippocampal | 4 | 2017 | 34 | 1.560 |
Why?
|
| Serotonin | 29 | 2008 | 123 | 1.530 |
Why?
|
| Memory Disorders | 9 | 2021 | 73 | 1.430 |
Why?
|
| Maze Learning | 19 | 2021 | 105 | 1.420 |
Why?
|
| Gonadal Steroid Hormones | 10 | 2012 | 51 | 1.340 |
Why?
|
| Sexual Behavior, Animal | 21 | 1999 | 53 | 1.160 |
Why?
|
| Aging | 13 | 2015 | 664 | 1.080 |
Why?
|
| Female | 98 | 2023 | 20969 | 1.070 |
Why?
|
| Endocrine Disruptors | 3 | 2022 | 39 | 1.060 |
Why?
|
| Benzhydryl Compounds | 6 | 2020 | 43 | 1.030 |
Why?
|
| Rodentia | 4 | 2020 | 43 | 1.030 |
Why?
|
| Anxiety | 7 | 2014 | 754 | 0.990 |
Why?
|
| Receptors, Estrogen | 10 | 2012 | 156 | 0.970 |
Why?
|
| Learning | 7 | 2020 | 117 | 0.950 |
Why?
|
| Hypothalamus | 26 | 1997 | 129 | 0.950 |
Why?
|
| Ovariectomy | 18 | 2016 | 105 | 0.900 |
Why?
|
| Estrogens, Non-Steroidal | 3 | 2012 | 19 | 0.890 |
Why?
|
| Restraint, Physical | 9 | 2013 | 20 | 0.890 |
Why?
|
| Steroids | 1 | 2023 | 43 | 0.860 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2012 | 61 | 0.840 |
Why?
|
| Male | 65 | 2023 | 20025 | 0.780 |
Why?
|
| Brain Chemistry | 13 | 2010 | 140 | 0.770 |
Why?
|
| Neurons | 11 | 2011 | 1175 | 0.740 |
Why?
|
| Spatial Behavior | 5 | 2010 | 22 | 0.700 |
Why?
|
| Behavior, Animal | 11 | 2021 | 314 | 0.680 |
Why?
|
| Memory, Short-Term | 5 | 2021 | 49 | 0.670 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2011 | 162 | 0.660 |
Why?
|
| Corticosterone | 13 | 2014 | 77 | 0.650 |
Why?
|
| Pyramidal Cells | 5 | 2014 | 63 | 0.650 |
Why?
|
| Neuronal Plasticity | 6 | 2015 | 103 | 0.640 |
Why?
|
| Pseudopodia | 1 | 2017 | 15 | 0.610 |
Why?
|
| Androgens | 5 | 2016 | 89 | 0.610 |
Why?
|
| Receptors, AMPA | 1 | 2017 | 56 | 0.600 |
Why?
|
| Choline O-Acetyltransferase | 15 | 1993 | 34 | 0.580 |
Why?
|
| Progesterone | 16 | 2010 | 113 | 0.550 |
Why?
|
| Gonadal Hormones | 1 | 2016 | 6 | 0.540 |
Why?
|
| Motor Activity | 7 | 2010 | 418 | 0.540 |
Why?
|
| Neuropsychological Tests | 3 | 2014 | 259 | 0.530 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2014 | 53 | 0.530 |
Why?
|
| Norepinephrine | 17 | 2010 | 110 | 0.530 |
Why?
|
| Hormones | 6 | 2023 | 55 | 0.520 |
Why?
|
| Time Factors | 18 | 2016 | 1742 | 0.520 |
Why?
|
| Estrogen Receptor beta | 3 | 2010 | 40 | 0.520 |
Why?
|
| Pregnancy | 8 | 2011 | 1549 | 0.500 |
Why?
|
| Cocaine | 4 | 2011 | 232 | 0.500 |
Why?
|
| Posture | 14 | 1999 | 58 | 0.470 |
Why?
|
| Dopamine | 11 | 2006 | 245 | 0.470 |
Why?
|
| Ethanol | 2 | 2013 | 192 | 0.470 |
Why?
|
| Neurotransmitter Agents | 7 | 2008 | 63 | 0.460 |
Why?
|
| Alcohols | 1 | 2013 | 12 | 0.460 |
Why?
|
| Postpartum Period | 2 | 2011 | 66 | 0.460 |
Why?
|
| Testosterone | 16 | 2016 | 193 | 0.460 |
Why?
|
| Pyrazoles | 2 | 2010 | 85 | 0.450 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2013 | 21 | 0.440 |
Why?
|
| Cognition Disorders | 5 | 2014 | 233 | 0.440 |
Why?
|
| Discrimination Learning | 3 | 2010 | 28 | 0.430 |
Why?
|
| Exploratory Behavior | 6 | 2013 | 75 | 0.430 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 37 | 0.430 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 59 | 0.420 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2004 | 79 | 0.420 |
Why?
|
| Parity | 2 | 2009 | 46 | 0.390 |
Why?
|
| Cerebral Cortex | 7 | 2010 | 290 | 0.380 |
Why?
|
| Central Nervous System | 2 | 2012 | 135 | 0.380 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2011 | 77 | 0.370 |
Why?
|
| Fluorenes | 1 | 2010 | 26 | 0.370 |
Why?
|
| Sex Differentiation | 2 | 2009 | 13 | 0.370 |
Why?
|
| Depression | 2 | 2013 | 712 | 0.360 |
Why?
|
| Methamphetamine | 2 | 2021 | 159 | 0.350 |
Why?
|
| Rats, Inbred F344 | 10 | 2010 | 245 | 0.350 |
Why?
|
| Hydroxyindoleacetic Acid | 12 | 2010 | 12 | 0.340 |
Why?
|
| Reproduction | 1 | 2009 | 71 | 0.340 |
Why?
|
| Body Weight | 5 | 2013 | 434 | 0.320 |
Why?
|
| Preoptic Area | 11 | 2008 | 15 | 0.310 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2007 | 1 | 0.310 |
Why?
|
| Neurotransmitter Transport Proteins | 1 | 2007 | 2 | 0.310 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 519 | 0.300 |
Why?
|
| Thiazepines | 3 | 1995 | 4 | 0.290 |
Why?
|
| Antidepressive Agents, Tricyclic | 3 | 1995 | 12 | 0.290 |
Why?
|
| 5,7-Dihydroxytryptamine | 7 | 1992 | 7 | 0.290 |
Why?
|
| Catecholamines | 5 | 1998 | 44 | 0.290 |
Why?
|
| Orchiectomy | 2 | 2017 | 35 | 0.290 |
Why?
|
| Analysis of Variance | 5 | 2013 | 550 | 0.290 |
Why?
|
| Phytoestrogens | 1 | 2006 | 38 | 0.280 |
Why?
|
| Pargyline | 7 | 1995 | 11 | 0.270 |
Why?
|
| Disease Models, Animal | 7 | 2013 | 1371 | 0.270 |
Why?
|
| Biogenic Amines | 4 | 1986 | 11 | 0.260 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2014 | 44 | 0.260 |
Why?
|
| Fluoxetine | 2 | 1995 | 11 | 0.260 |
Why?
|
| Sex Factors | 8 | 2021 | 898 | 0.250 |
Why?
|
| Humans | 29 | 2020 | 37093 | 0.250 |
Why?
|
| Synaptophysin | 1 | 2004 | 5 | 0.250 |
Why?
|
| Chronic Disease | 5 | 2007 | 484 | 0.250 |
Why?
|
| Amphetamine | 1 | 2004 | 16 | 0.240 |
Why?
|
| Amygdala | 9 | 2009 | 114 | 0.240 |
Why?
|
| Neurosecretory Systems | 2 | 2010 | 16 | 0.240 |
Why?
|
| Behavior | 3 | 2020 | 32 | 0.240 |
Why?
|
| Proline | 2 | 2002 | 43 | 0.220 |
Why?
|
| Dextroamphetamine | 1 | 2003 | 10 | 0.220 |
Why?
|
| Dihydroxytryptamines | 4 | 1987 | 4 | 0.220 |
Why?
|
| Central Nervous System Stimulants | 2 | 2021 | 174 | 0.220 |
Why?
|
| Indans | 1 | 2002 | 13 | 0.220 |
Why?
|
| Benzopyrans | 1 | 2002 | 14 | 0.220 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2002 | 43 | 0.210 |
Why?
|
| Food Deprivation | 3 | 1999 | 30 | 0.210 |
Why?
|
| Piperidines | 1 | 2002 | 77 | 0.210 |
Why?
|
| Sexual Maturation | 2 | 2020 | 23 | 0.210 |
Why?
|
| Rats, Inbred Strains | 18 | 1991 | 133 | 0.210 |
Why?
|
| Nicotinic Agonists | 1 | 2002 | 75 | 0.210 |
Why?
|
| Monoamine Oxidase | 7 | 1986 | 34 | 0.200 |
Why?
|
| Corpus Striatum | 1 | 2002 | 104 | 0.190 |
Why?
|
| Genomics | 1 | 2023 | 223 | 0.190 |
Why?
|
| Proestrus | 2 | 2007 | 2 | 0.190 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2021 | 65 | 0.190 |
Why?
|
| Synapses | 5 | 2006 | 180 | 0.190 |
Why?
|
| Neuroprotective Agents | 1 | 2003 | 245 | 0.180 |
Why?
|
| Castration | 16 | 1986 | 34 | 0.180 |
Why?
|
| Neuroendocrinology | 1 | 2020 | 2 | 0.180 |
Why?
|
| Neural Pathways | 4 | 2008 | 124 | 0.180 |
Why?
|
| Golgi Apparatus | 2 | 2012 | 27 | 0.180 |
Why?
|
| History, 21st Century | 1 | 2020 | 81 | 0.180 |
Why?
|
| History, 20th Century | 1 | 2020 | 117 | 0.170 |
Why?
|
| Form Perception | 1 | 1999 | 4 | 0.170 |
Why?
|
| Animals, Newborn | 4 | 2011 | 343 | 0.170 |
Why?
|
| Amino Acids | 1 | 1999 | 145 | 0.160 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 3 | 2010 | 27 | 0.160 |
Why?
|
| Mental Recall | 2 | 1997 | 78 | 0.160 |
Why?
|
| Radioimmunoassay | 3 | 2012 | 65 | 0.150 |
Why?
|
| Pituitary Gland | 9 | 1986 | 63 | 0.150 |
Why?
|
| Administration, Oral | 3 | 2021 | 224 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 2 | 2010 | 111 | 0.140 |
Why?
|
| Acetylcholinesterase | 8 | 1984 | 55 | 0.140 |
Why?
|
| Postmenopause | 1 | 1997 | 128 | 0.140 |
Why?
|
| Psychomotor Performance | 2 | 2013 | 136 | 0.140 |
Why?
|
| Glutamic Acid | 1 | 1997 | 128 | 0.130 |
Why?
|
| Acetylcholine | 2 | 1993 | 73 | 0.130 |
Why?
|
| Receptors, Cholinergic | 4 | 1984 | 28 | 0.130 |
Why?
|
| Menopause | 1 | 2014 | 56 | 0.120 |
Why?
|
| Imipramine | 2 | 1985 | 8 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 169 | 0.120 |
Why?
|
| Anxiety Disorders | 2 | 2008 | 309 | 0.120 |
Why?
|
| Silver Staining | 2 | 2011 | 7 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2002 | 421 | 0.120 |
Why?
|
| Swimming | 1 | 2013 | 38 | 0.110 |
Why?
|
| Longevity | 1 | 2015 | 147 | 0.110 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 2010 | 15 | 0.110 |
Why?
|
| Prosencephalon | 1 | 1993 | 25 | 0.110 |
Why?
|
| Receptors, GABA | 1 | 2013 | 25 | 0.110 |
Why?
|
| Uterus | 3 | 2006 | 55 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2014 | 216 | 0.110 |
Why?
|
| Visual Perception | 3 | 2014 | 67 | 0.110 |
Why?
|
| Age Factors | 5 | 2014 | 1033 | 0.110 |
Why?
|
| Adrenalectomy | 7 | 1994 | 25 | 0.100 |
Why?
|
| Ovary | 8 | 1977 | 108 | 0.100 |
Why?
|
| Baclofen | 1 | 1991 | 8 | 0.100 |
Why?
|
| Choice Behavior | 1 | 2012 | 79 | 0.100 |
Why?
|
| Frontal Lobe | 4 | 1994 | 48 | 0.100 |
Why?
|
| Stimulation, Chemical | 2 | 2002 | 22 | 0.100 |
Why?
|
| Fenfluramine | 1 | 2010 | 2 | 0.090 |
Why?
|
| Weight Gain | 2 | 2004 | 136 | 0.090 |
Why?
|
| Propionates | 1 | 2010 | 26 | 0.090 |
Why?
|
| Neostriatum | 1 | 2010 | 26 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 859 | 0.090 |
Why?
|
| Dendrites | 2 | 2004 | 55 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 108 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 187 | 0.090 |
Why?
|
| Nitriles | 1 | 2010 | 69 | 0.090 |
Why?
|
| Cell Nucleus | 7 | 1986 | 366 | 0.090 |
Why?
|
| Monoamine Oxidase Inhibitors | 2 | 1995 | 25 | 0.080 |
Why?
|
| Dynorphins | 1 | 2008 | 14 | 0.080 |
Why?
|
| Maternal Behavior | 1 | 2008 | 22 | 0.080 |
Why?
|
| Glucosephosphate Dehydrogenase | 8 | 1986 | 16 | 0.080 |
Why?
|
| Receptors, Progesterone | 3 | 1987 | 81 | 0.080 |
Why?
|
| Organ Size | 2 | 2006 | 157 | 0.080 |
Why?
|
| Muscles | 3 | 1984 | 82 | 0.080 |
Why?
|
| Drug Administration Schedule | 2 | 2002 | 143 | 0.080 |
Why?
|
| Synaptic Transmission | 2 | 2007 | 146 | 0.080 |
Why?
|
| Septum of Brain | 1 | 2007 | 1 | 0.080 |
Why?
|
| Ovulation | 1 | 2007 | 20 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2011 | 517 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 1609 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2007 | 1039 | 0.070 |
Why?
|
| Receptors, Cell Surface | 3 | 1978 | 144 | 0.070 |
Why?
|
| Mothers | 1 | 2009 | 181 | 0.070 |
Why?
|
| Trachea | 2 | 1984 | 25 | 0.070 |
Why?
|
| Vocalization, Animal | 3 | 1984 | 22 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 85 | 0.070 |
Why?
|
| Food, Formulated | 1 | 2006 | 4 | 0.070 |
Why?
|
| Cortisone | 1 | 2006 | 3 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 109 | 0.070 |
Why?
|
| Cholinergic Fibers | 3 | 1993 | 10 | 0.070 |
Why?
|
| Problem Solving | 1 | 2006 | 35 | 0.070 |
Why?
|
| Association Learning | 1 | 2006 | 30 | 0.070 |
Why?
|
| Limbic System | 2 | 1985 | 25 | 0.070 |
Why?
|
| Estrous Cycle | 2 | 2008 | 35 | 0.070 |
Why?
|
| Diencephalon | 1 | 1986 | 7 | 0.070 |
Why?
|
| Telencephalon | 1 | 1986 | 14 | 0.070 |
Why?
|
| Alzheimer Disease | 5 | 1997 | 905 | 0.070 |
Why?
|
| Action Potentials | 1 | 2007 | 231 | 0.070 |
Why?
|
| Homovanillic Acid | 2 | 2002 | 10 | 0.070 |
Why?
|
| Reference Values | 3 | 1994 | 212 | 0.070 |
Why?
|
| Naloxone | 1 | 1985 | 52 | 0.060 |
Why?
|
| Raphe Nuclei | 1 | 1984 | 6 | 0.060 |
Why?
|
| Naltrexone | 1 | 1985 | 38 | 0.060 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 1993 | 78 | 0.060 |
Why?
|
| Neuromuscular Junction | 2 | 1982 | 33 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2004 | 18 | 0.060 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1984 | 9 | 0.060 |
Why?
|
| Pyramidal Tracts | 2 | 1994 | 13 | 0.060 |
Why?
|
| Vitamin D | 1 | 1987 | 196 | 0.060 |
Why?
|
| Pregnant Women | 1 | 2004 | 48 | 0.060 |
Why?
|
| Testis | 2 | 1975 | 187 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2006 | 513 | 0.060 |
Why?
|
| Diethylstilbestrol | 1 | 2003 | 6 | 0.060 |
Why?
|
| Periaqueductal Gray | 2 | 1993 | 10 | 0.060 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 2 | 1993 | 6 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2003 | 32 | 0.060 |
Why?
|
| Mice | 5 | 2021 | 5913 | 0.060 |
Why?
|
| Birds | 4 | 1984 | 28 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2008 | 609 | 0.050 |
Why?
|
| Housing, Animal | 1 | 2002 | 11 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2006 | 1369 | 0.050 |
Why?
|
| Nitromifene | 2 | 1982 | 2 | 0.050 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2021 | 22 | 0.050 |
Why?
|
| Reaction Time | 1 | 2002 | 143 | 0.050 |
Why?
|
| Pyrrolidines | 2 | 1982 | 29 | 0.050 |
Why?
|
| Hydrocortisone | 2 | 1999 | 78 | 0.050 |
Why?
|
| Receptors, Steroid | 4 | 1984 | 36 | 0.050 |
Why?
|
| Receptors, Glucocorticoid | 3 | 1994 | 34 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2021 | 120 | 0.050 |
Why?
|
| Laryngeal Nerves | 1 | 1980 | 10 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 3 | 2004 | 360 | 0.050 |
Why?
|
| Endorphins | 2 | 1993 | 4 | 0.050 |
Why?
|
| Anisomycin | 3 | 1985 | 8 | 0.040 |
Why?
|
| Motor Neurons | 1 | 1980 | 83 | 0.040 |
Why?
|
| Luteinizing Hormone | 4 | 1987 | 63 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1207 | 0.040 |
Why?
|
| Bicuculline | 1 | 1999 | 18 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 1993 | 207 | 0.040 |
Why?
|
| GABA Antagonists | 1 | 1999 | 29 | 0.040 |
Why?
|
| Proline Oxidase | 1 | 1999 | 11 | 0.040 |
Why?
|
| Catechol O-Methyltransferase | 1 | 1998 | 12 | 0.040 |
Why?
|
| Mossy Fibers, Hippocampal | 2 | 2008 | 10 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 1978 | 133 | 0.040 |
Why?
|
| Hypothalamus, Middle | 1 | 1977 | 4 | 0.040 |
Why?
|
| Autoantibodies | 2 | 1988 | 103 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1995 | 98 | 0.030 |
Why?
|
| Mesencephalon | 2 | 1991 | 41 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 1975 | 27 | 0.030 |
Why?
|
| Orientation | 1 | 1994 | 29 | 0.030 |
Why?
|
| Cell Count | 1 | 2014 | 135 | 0.030 |
Why?
|
| Phenytoin | 1 | 1994 | 2 | 0.030 |
Why?
|
| Aldosterone | 1 | 1994 | 66 | 0.030 |
Why?
|
| Receptors, Opioid, delta | 1 | 1993 | 23 | 0.030 |
Why?
|
| Median Eminence | 1 | 1993 | 10 | 0.030 |
Why?
|
| Injections | 1 | 1993 | 35 | 0.030 |
Why?
|
| Myelin Sheath | 2 | 2010 | 48 | 0.030 |
Why?
|
| Receptors, Opioid, mu | 1 | 1993 | 55 | 0.030 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1993 | 9 | 0.030 |
Why?
|
| Microfilament Proteins | 2 | 2004 | 69 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 1993 | 37 | 0.030 |
Why?
|
| NADP | 2 | 1979 | 38 | 0.030 |
Why?
|
| Cytosol | 4 | 1987 | 93 | 0.030 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 1992 | 6 | 0.030 |
Why?
|
| Mammals | 1 | 1993 | 105 | 0.030 |
Why?
|
| Brain Mapping | 1 | 1993 | 112 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1991 | 24 | 0.030 |
Why?
|
| Piperazines | 1 | 1992 | 111 | 0.020 |
Why?
|
| Aged | 5 | 1997 | 6741 | 0.020 |
Why?
|
| Kinetics | 4 | 1989 | 708 | 0.020 |
Why?
|
| Arousal | 1 | 1991 | 86 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 1984 | 444 | 0.020 |
Why?
|
| Electrochemistry | 1 | 1990 | 34 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1971 | 94 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 893 | 0.020 |
Why?
|
| Vasopressins | 1 | 1990 | 13 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2010 | 29 | 0.020 |
Why?
|
| Sesame Oil | 1 | 2010 | 2 | 0.020 |
Why?
|
| Phosphogluconate Dehydrogenase | 3 | 1975 | 3 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 1975 | 8 | 0.020 |
Why?
|
| Malate Dehydrogenase | 3 | 1975 | 7 | 0.020 |
Why?
|
| Epinephrine | 1 | 1989 | 36 | 0.020 |
Why?
|
| Neurochemistry | 2 | 2004 | 6 | 0.020 |
Why?
|
| Lipids | 1 | 1971 | 235 | 0.020 |
Why?
|
| Prolactin | 2 | 2004 | 62 | 0.020 |
Why?
|
| Antibodies | 1 | 1989 | 141 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2008 | 34 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 204 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 269 | 0.020 |
Why?
|
| Diestrus | 1 | 2007 | 1 | 0.020 |
Why?
|
| Time | 1 | 2007 | 14 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 623 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 35 | 0.020 |
Why?
|
| Middle Aged | 4 | 1997 | 10129 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2007 | 103 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2007 | 79 | 0.020 |
Why?
|
| Pituitary-Adrenal System | 1 | 1987 | 39 | 0.020 |
Why?
|
| Recurrence | 1 | 2007 | 131 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1987 | 18 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 1987 | 22 | 0.020 |
Why?
|
| Heparitin Sulfate | 1 | 1987 | 23 | 0.020 |
Why?
|
| Muscle Denervation | 2 | 1984 | 4 | 0.020 |
Why?
|
| Reward | 1 | 2007 | 79 | 0.020 |
Why?
|
| Glycerolphosphate Dehydrogenase | 2 | 1984 | 4 | 0.020 |
Why?
|
| Proteoglycans | 1 | 1987 | 47 | 0.020 |
Why?
|
| Androstatrienes | 1 | 1986 | 1 | 0.020 |
Why?
|
| Proteins | 2 | 1982 | 369 | 0.020 |
Why?
|
| Calcitriol | 1 | 1986 | 31 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 1180 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 1987 | 237 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 1985 | 64 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 1568 | 0.020 |
Why?
|
| Estrogens, Catechol | 2 | 1982 | 2 | 0.020 |
Why?
|
| Hexokinase | 2 | 1975 | 10 | 0.020 |
Why?
|
| Denervation | 1 | 1984 | 27 | 0.020 |
Why?
|
| Spinal Puncture | 1 | 2004 | 2 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 1975 | 62 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1985 | 141 | 0.020 |
Why?
|
| Ganglia, Sympathetic | 1 | 1984 | 3 | 0.020 |
Why?
|
| Fetus | 1 | 1984 | 105 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 435 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 209 | 0.020 |
Why?
|
| Oxytocin | 1 | 2004 | 25 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2004 | 130 | 0.010 |
Why?
|
| Androsterone | 1 | 1983 | 1 | 0.010 |
Why?
|
| Androstenedione | 1 | 1983 | 17 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1983 | 29 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 1983 | 14 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 53 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1984 | 131 | 0.010 |
Why?
|
| Tritium | 1 | 1983 | 51 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1015 | 0.010 |
Why?
|
| Binding Sites | 1 | 1985 | 651 | 0.010 |
Why?
|
| Radioimmunodetection | 1 | 2002 | 1 | 0.010 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2002 | 5 | 0.010 |
Why?
|
| Histological Techniques | 1 | 2002 | 14 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1983 | 161 | 0.010 |
Why?
|
| Clorgyline | 1 | 1982 | 4 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 661 | 0.010 |
Why?
|
| Progestins | 1 | 1982 | 12 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 3562 | 0.010 |
Why?
|
| Choline | 2 | 1988 | 59 | 0.010 |
Why?
|
| Hydroxyestrones | 1 | 1981 | 8 | 0.010 |
Why?
|
| Estrone | 1 | 1981 | 21 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2000 | 33 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 1980 | 18 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 60 | 0.010 |
Why?
|
| Laryngeal Muscles | 1 | 1980 | 6 | 0.010 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1999 | 4 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 80 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 150 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 1999 | 66 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1999 | 39 | 0.010 |
Why?
|
| Cell Fractionation | 2 | 1977 | 30 | 0.010 |
Why?
|
| Insect Proteins | 1 | 1999 | 50 | 0.010 |
Why?
|
| RNA | 2 | 1978 | 241 | 0.010 |
Why?
|
| Homozygote | 1 | 1998 | 77 | 0.010 |
Why?
|
| Heterozygote | 1 | 1998 | 93 | 0.010 |
Why?
|
| Autoradiography | 2 | 1993 | 36 | 0.010 |
Why?
|
| Phenethylamines | 1 | 1977 | 1 | 0.010 |
Why?
|
| Cricetinae | 1 | 1978 | 238 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1977 | 74 | 0.010 |
Why?
|
| Ganglia, Autonomic | 1 | 1977 | 4 | 0.010 |
Why?
|
| Substantia Nigra | 1 | 1977 | 44 | 0.010 |
Why?
|
| NAD | 2 | 1979 | 50 | 0.010 |
Why?
|
| Hydroxydopamines | 2 | 1987 | 4 | 0.010 |
Why?
|
| Oxidopamine | 2 | 1987 | 20 | 0.010 |
Why?
|
| Phenotype | 1 | 1998 | 689 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 1998 | 933 | 0.010 |
Why?
|
| Atrophy | 1 | 1995 | 42 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1998 | 309 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 1095 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1994 | 107 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 1989 | 2379 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1992 | 20 | 0.010 |
Why?
|
| Receptors, Serotonin | 1 | 1992 | 22 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 894 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1992 | 233 | 0.010 |
Why?
|
| Glyceraldehyde | 1 | 1971 | 3 | 0.010 |
Why?
|
| Malates | 1 | 1971 | 3 | 0.010 |
Why?
|
| Fluorometry | 1 | 1971 | 17 | 0.010 |
Why?
|
| Transferases | 1 | 1971 | 12 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1971 | 50 | 0.010 |
Why?
|
| Rabbits | 1 | 1971 | 283 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 1991 | 155 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1989 | 3 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1971 | 431 | 0.010 |
Why?
|
| Synaptosomes | 1 | 1988 | 21 | 0.010 |
Why?
|
| Adult | 1 | 2004 | 11712 | 0.010 |
Why?
|
| Prazosin | 1 | 1987 | 11 | 0.000 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1987 | 12 | 0.000 |
Why?
|
| Blood Vessels | 1 | 1987 | 34 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1987 | 145 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1987 | 189 | 0.000 |
Why?
|
| Calcifediol | 1 | 1986 | 15 | 0.000 |
Why?
|
| Vaginal Diseases | 1 | 1986 | 9 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1986 | 45 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1987 | 448 | 0.000 |
Why?
|
| Blood-Brain Barrier | 1 | 1987 | 162 | 0.000 |
Why?
|
| Uterine Neoplasms | 1 | 1986 | 39 | 0.000 |
Why?
|
| Precancerous Conditions | 1 | 1986 | 82 | 0.000 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1986 | 107 | 0.000 |
Why?
|
| Hypophysectomy | 1 | 1984 | 4 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1984 | 45 | 0.000 |
Why?
|
| Calcium | 1 | 1986 | 480 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1982 | 12 | 0.000 |
Why?
|
| alpha-Fetoproteins | 1 | 1982 | 31 | 0.000 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1980 | 2 | 0.000 |
Why?
|
| Receptors, Androgen | 1 | 1982 | 126 | 0.000 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1977 | 10 | 0.000 |
Why?
|
| Species Specificity | 1 | 1977 | 245 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1975 | 129 | 0.000 |
Why?
|